Vistagen Therapeutics, Inc. · NASDAQ:VTGN
Orbimed Advisors LLC reported a 4.20% stake in Vistagen Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Orbimed Advisors LLC reported a 4.20% stake in Vistagen Therapeutics, Inc., 1,639,700 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 4.20%
- Shares
- 1,639,700
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ORBIMED ADVISORS LLC | 3.60% | 1,420,300 |
| ORBIMED CAPITAL LLC | 4.20% | 1,639,700 |
Source
Related
- Vistagen Therapeutics, Inc.
- Orbimed Advisors LLC
- Vistagen Therapeutics, Inc. shareholders
- Schedule 13G/A · Orbimed Advisors LLC · Aug 14, 2026
- Schedule 13G · Orbimed Advisors LLC · Nov 14, 2025
- Schedule 13G/A · Commodore Capital LP · Aug 14, 2026
- Schedule 13G/A · TCG Crossover GP I, LLC · Aug 14, 2026
- Form 4 · Adler Reid G. · Jul 2, 2026
- Form 4 · Tressler Nick B. · Jul 2, 2026
- Form 4 · Singh Shawn · Jul 2, 2026